Skip to main content
Clinical Trials/ISRCTN08132825
ISRCTN08132825
Completed
Not Applicable

Hypitat: Pregnancy-induced hypertension and pre-eclampsia after 36 weeks: induction of labour versus expectant monitoring. A comparison of maternal and neonatal outcome, maternal quality of life and costs.

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)0 sites250 target enrollmentDecember 20, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
Enrollment
250
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria (as of 22/08/2007\):
  • 1\. Pregnant women with gestational age 36 0/7 weeks until 41 0/7 weeks
  • 2\. Blood pressure greater than 140/95 mmHg in women with pregnancy induced hypertension
  • 3\. Blood pressure greater than 140/90 mmHg combined with proteinuria (greater than 300 mg/24 hours) in women with preeclampsia
  • Previous inclusion criteria:
  • 1\. Pregnant women with gestational age 36 0/7 wks until 41 0/7 wks
  • 2\. Blood pressure greater than 140/95 mmHg. Eventually combined with proteinuria (greater than 300 mg/24 hour)

Exclusion Criteria

  • 1\. Treated hypertension before pregnancy
  • 2\. Diabetes mellitus
  • 3\. Renal disease and previous caesarean section
  • 4\. HELLP syndrome
  • 5\. Oluguria
  • 6\. Cerebral or visual disturbances
  • 7\. Pulmonary oedema or cyanosis
  • 8\. Non\-vertex position

Outcomes

Primary Outcomes

Not specified

Similar Trials